These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 17601524)
1. Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis. Reddy RD; Keshavan MS; Yao JK Clin Biochem; 2007 Sep; 40(13-14):1081-3. PubMed ID: 17601524 [TBL] [Abstract][Full Text] [Related]
2. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia. Reddy R; Keshavan M; Yao JK Schizophr Res; 2007 Feb; 90(1-3):81-5. PubMed ID: 17204398 [TBL] [Abstract][Full Text] [Related]
3. Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia. Yao JK; van Kammen DP; Moss HB; Sokulski DE Psychiatry Res; 1996 Jul; 63(2-3):123-32. PubMed ID: 8878308 [TBL] [Abstract][Full Text] [Related]
4. Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Stahl SM; Woo DJ; Mefford IN; Berger PA; Ciaranello RD Am J Psychiatry; 1983 Jan; 140(1):26-30. PubMed ID: 6401198 [TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis. Marcinko D; Pivac N; Martinac M; Jakovljević M; Mihaljević-Peles A; Muck-Seler D Psychiatry Res; 2007 Feb; 150(1):105-8. PubMed ID: 17270280 [TBL] [Abstract][Full Text] [Related]
6. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects. Oppenheim B; Hefez A; Youdim MB Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729 [TBL] [Abstract][Full Text] [Related]
7. Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Yao JK; Magan S; Sonel AF; Gurklis JA; Sanders R; Reddy RD Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):171-6. PubMed ID: 15253886 [TBL] [Abstract][Full Text] [Related]
8. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. McBride PA; Anderson GM; Hertzig ME; Sweeney JA; Kream J; Cohen DJ; Mann JJ Arch Gen Psychiatry; 1989 Mar; 46(3):213-21. PubMed ID: 2919950 [TBL] [Abstract][Full Text] [Related]
9. Platelet serotonin and serum lipids in psychotic mania. Sagud M; Mihaljevic-Peles A; Pivac N; Jakovljevic M; Muck-Seler D J Affect Disord; 2007 Jan; 97(1-3):247-51. PubMed ID: 16820211 [TBL] [Abstract][Full Text] [Related]
10. [Platelet serotonergic parameters and clinical symptoms of psychosis in patients with episodic progressive schizophrenia]. Brusov OS; Faktor MI; Zlobina GP; Dupin AM; Katasonov AB; Dmitriev AD; Pavlova EV; Beniashvili AG; Morozova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):17-24. PubMed ID: 18379499 [TBL] [Abstract][Full Text] [Related]
11. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology. Jackman H; Luchins D; Meltzer HY Biol Psychiatry; 1983 Aug; 18(8):887-902. PubMed ID: 6615945 [TBL] [Abstract][Full Text] [Related]
12. Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response. Meltzer HY; Perline R; Lewine R J Nerv Ment Dis; 1982 Dec; 170(12):758-65. PubMed ID: 6754871 [TBL] [Abstract][Full Text] [Related]
14. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035 [TBL] [Abstract][Full Text] [Related]
15. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591 [TBL] [Abstract][Full Text] [Related]
16. The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients. Orr MW; Knox JM; Allen R; Gelder MG; Grahame-Smith DG Br J Clin Pharmacol; 1981 Mar; 11(3):255-9. PubMed ID: 6111333 [TBL] [Abstract][Full Text] [Related]
17. Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis. Arranz B; San L; Ramírez N; Dueñas RM; Perez V; Salavert J; Corripio I; Alvarez E Acta Psychiatr Scand; 2009 Jan; 119(1):71-7. PubMed ID: 18764839 [TBL] [Abstract][Full Text] [Related]
18. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro. Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939 [TBL] [Abstract][Full Text] [Related]
19. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression. Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378 [TBL] [Abstract][Full Text] [Related]
20. Combined use of platelet serotonergic markers and psychopathological scales as diagnostic screening of a psychotic versus a depressive disorder. Ramirez N; Arranz B; Martín C; San L Eur Psychiatry; 2003 Nov; 18(7):369-71. PubMed ID: 14643567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]